EVP & General Manager US of Incyte Corp (30-Year Financial, Insider Trades) Barry P Flannelly (insider trades) sold 6,583 shares of INCY on 04/17/2020 at an average price of $100 a share. The total sale was $658,300.
Incyte Corp is a biopharmaceutical company. It discovers, develops and commercializes proprietary therapeutics. Its product JAKAFI, a JAK1 and JAK2 inhibitor is used for treatment of patients with intermediate or high risk myelofibrosis. Incyte Corp has a market cap of $21.56 billion; its shares were traded at around $99.46 with a P/E ratio of 48.52 and P/S ratio of 10.02. GuruFocus has detected 1 severe warning sign with Incyte Corp. .
Directors and Officers Recent Trades:
- EVP & General Counsel Maria E Pasquale sold 18,976 shares of INCY stock on 04/17/2020 at the average price of $97.5. The price of the stock has increased by 2.01% since.
- Principal Accounting Officer Paul Trower sold 1,143 shares of INCY stock on 04/17/2020 at the average price of $100. The price of the stock has decreased by 0.54% since.
- EVP & General Manager US Barry P Flannelly sold 6,583 shares of INCY stock on 04/17/2020 at the average price of $100. The price of the stock has decreased by 0.54% since.
- EVP & General Counsel Maria E Pasquale sold 18,792 shares of INCY stock on 04/14/2020 at the average price of $89.78. The price of the stock has increased by 10.78% since.
- EVP & General Counsel Maria E Pasquale sold 1,842 shares of INCY stock on 04/06/2020 at the average price of $85. The price of the stock has increased by 17.01% since.
For the complete insider trading history of INCY, click here
.
